Clinical trials
Phase 1/2 Acquired Immunodeficiency Syndrome trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2013 | 4 |
| 2014 | 4 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Withdrawn | 2 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of California, San Francisco | 5 |
| National Cancer Institute (NCI) | 3 |
| Diane George | 2 |
| Yale University | 2 |
| Boris Juelg, MD PhD | 1 |
| Calimmune, Inc. | 1 |
| Centers for Disease Control and Prevention | 1 |
| Georgetown University | 1 |
| Hektoen Institute for Medical Research | 1 |
| International AIDS Vaccine Initiative | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acquired Immunodeficiency Syndrome | 30 |
| HIV Infections | 5 |
| Sarcoma, Kaposi | 3 |
| Substance-Related Disorders | 3 |
| Anemia, Aplastic | 2 |
| Anemia, Diamond-Blackfan | 2 |
| Anemia, Sickle Cell | 2 |
| Bone Marrow Failure Disorders | 2 |
| Hemoglobinopathies | 2 |
| Histiocytosis | 2 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.